Vor Biopharma Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Vor Biopharma Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
- Vor Biopharma Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.79M, a 34.1% decline year-over-year.
- Vor Biopharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $10.9M, a 29.5% decline year-over-year.
- Vor Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.4M, a 24.9% increase from 2022.
- Vor Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.7M, a 148% increase from 2021.
- Vor Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.32M, a 222% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)